Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new ...

Scientists at UCSF have uncovered how certain immune cells in the brain, called microglia, can effectively digest toxic ...

Dementia is a group of diseases that involve having trouble with memory, thinking, reasoning and other brain functions. It is ...

UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

An Alzheimer’s “wonder drug” can delay the progression of the disease by four years, according to a new study. Researchers ...

Dementia can feel like a scary word but knowing what it means and how to spot the signs early can make a big difference.

TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...

Adults with a father who had Alzheimer’s showed greater tau buildup, a key marker of the disease. Women in the study had more widespread tau in the ...

Groundbreaking new Alzheimer’s treatment could give patients four years of better health. Patients who participated in the ...

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the first to market, commercial launch of two novel phospho-tau ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

The model reveals that more connected brain regions are more prone to damage, while isolated areas remain resilient. This approach offers a powerful framework for understanding disease progression and ...